Alliance Pharma PLC Annual Report and AGM Notice (7905J)
April 10 2015 - 2:00AM
UK Regulatory
TIDMAPH
RNS Number : 7905J
Alliance Pharma PLC
10 April 2015
For Immediate Release 10 April 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Annual Report and AGM Notice
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, is pleased to announce that its 2014 Annual Report and
Accounts and Notice of Annual General Meeting, which will be held
on 27 May 2015, are now available on the Company's website at
www.alliancepharma.co.uk.
Printed copies of both documents will be posted to shareholders
shortly and may also be requested by email at
ir@alliancepharma.co.uk.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane
Glover
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade /
Freddie Barnfield
Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDMGGDKLLGKZM
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024